跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ATORVASTATIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ATORVASTATIN
Authorized
STANDARD
ATORVASTATIN
angita pharma inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
62e62d07cbc37a21
Company
angita pharma inc.
Type
Standard
Approval Details
Approval Id
62e62d07cbc37a21
Drug Approval Canada Name
ATORVASTATIN
Product Name
ATORVASTATIN
Status
Marketed
Status Date
2022-02-01
Original Market Date
2022-02-01
Din
02506076
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:06.08
Atc Original
C10AA05 ATORVASTATIN
Atc Name
c 10 aa 05
Aig Number
0133055001
Company Name
angita pharma inc.
Company Address
1310 Rue Nobel, Boucherville, Quebec, Canada, J4B 5H3
Active Ingredients
ATORVASTATIN (ATORVASTATIN CALCIUM)
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
62e62d07cbc37a21
Type
Standard
Back to Health Canada Approvals